NCT00051675View on ClinicalTrials.gov

Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

September 30, 2003

Conditions
Adenocarcinoma
Interventions
DRUG

ING-1(heMAb)

Trial Locations (1)

10461

Jack D. Weiler Hospital of the Albert Einstein College of Medicine, The Bronx

All Listed Sponsors
lead

XOMA (US) LLC

INDUSTRY

NCT00051675 - Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas | Biotech Hunter | Biotech Hunter